Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0041 USD | +36.67% | 0.00% | +4,000.00% |
Business Summary
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 4 | 100.0 % | 2 | 100.0 % | -56.22% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | 2 | 100.0 % | -56.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 06/04/08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 31/01/98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 28/02/98 |
Albert Brzeczko
PRN | Corporate Officer/Principal | 67 | 31/01/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 31/01/98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 28/02/98 |
William Skelly
BRD | Director/Board Member | 73 | 30/04/96 |
Director/Board Member | 53 | 30/11/02 | |
George Ross
BRD | Director/Board Member | 82 | 31/12/07 |
Robert Jones
CEO | Chief Executive Officer | 65 | 06/04/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,001,783 | 9,642,826 ( 14.61 %) | 0 | 14.61 % |
Company contact information
Acura Pharmaceuticals, Inc.
616 N. North Court Suite 120
60067, Palatine
+847 705 7709
http://www.acurapharm.comSector
1st Jan change | Capi. | |
---|---|---|
+4,000.00% | 272K | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- ACUR Stock
- Company Acura Pharmaceuticals, Inc.